Stericycle Inc (NASDAQ:SRCL) has been given an average recommendation of “Hold” by the sixteen research firms that are covering the company. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $89.10.
Several equities research analysts recently commented on SRCL shares. Jefferies Group LLC set a $108.00 price objective on shares of Stericycle and gave the stock a “buy” rating in a research note on Thursday, March 16th. Macquarie set a $100.00 target price on shares of Stericycle and gave the stock a “buy” rating in a research note on Monday, February 6th. Stifel Nicolaus set a $90.00 target price on shares of Stericycle and gave the stock a “buy” rating in a research note on Monday, February 6th. Zacks Investment Research upgraded shares of Stericycle from a “sell” rating to a “hold” rating in a research note on Friday, January 13th. Finally, Raymond James Financial, Inc. reiterated a “market perform” rating on shares of Stericycle in a research note on Monday, February 20th.
Stericycle (NASDAQ:SRCL) traded up 0.52% on Monday, reaching $85.56. The company’s stock had a trading volume of 727,384 shares. The company has a market cap of $7.29 billion, a P/E ratio of 41.13 and a beta of 0.08. Stericycle has a 12 month low of $71.52 and a 12 month high of $125.04. The stock’s 50 day moving average price is $82.17 and its 200 day moving average price is $78.34.
Stericycle (NASDAQ:SRCL) last posted its quarterly earnings data on Wednesday, February 15th. The business services provider reported $1.00 EPS for the quarter, topping the consensus estimate of $0.93 by $0.07. Stericycle had a net margin of 7.52% and a return on equity of 15.33%. The business had revenue of $906.40 million for the quarter, compared to analyst estimates of $902.62 million. During the same quarter in the previous year, the firm posted $1.11 earnings per share. Equities research analysts forecast that Stericycle will post $4.62 earnings per share for the current year.
WARNING: This piece of content was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this piece of content on another site, it was illegally copied and reposted in violation of US and international copyright & trademark law. The legal version of this piece of content can be read at https://sportsperspectives.com/2017/04/21/stericycle-inc-srcl-given-average-rating-of-hold-by-brokerages-updated-updated.html.
In related news, Director Robert S. Murley acquired 1,000 shares of the firm’s stock in a transaction dated Wednesday, February 1st. The stock was purchased at an average cost of $76.22 per share, with a total value of $76,220.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Mike S. Zafirovski acquired 2,920 shares of the firm’s stock in a transaction dated Thursday, February 23rd. The shares were bought at an average cost of $85.67 per share, with a total value of $250,156.40. Following the completion of the acquisition, the director now directly owns 2,920 shares of the company’s stock, valued at $250,156.40. The disclosure for this purchase can be found here. 3.30% of the stock is owned by insiders.
Hedge funds have recently made changes to their positions in the stock. Capital Analysts LLC boosted its stake in shares of Stericycle by 6.2% in the fourth quarter. Capital Analysts LLC now owns 1,294 shares of the business services provider’s stock worth $100,000 after buying an additional 76 shares in the last quarter. Pacad Investment Ltd. acquired a new stake in shares of Stericycle during the fourth quarter worth approximately $100,000. Fuller & Thaler Asset Management Inc. acquired a new stake in shares of Stericycle during the third quarter worth approximately $136,000. Parallel Advisors LLC acquired a new stake in shares of Stericycle during the fourth quarter worth approximately $140,000. Finally, Amica Retiree Medical Trust acquired a new stake in shares of Stericycle during the third quarter worth approximately $150,000. 94.49% of the stock is owned by institutional investors and hedge funds.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc and related companies with MarketBeat.com's FREE daily email newsletter.